Kyverna Therapeutics, Inc.KYTXNASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank100
3Y CAGR+8.3%
Studio
Year-over-Year Change

Cash on hand plus short-term liquid investments

3Y CAGR
+8.3%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
1.3x
Solid growth
Streak
1 yr
Consecutive growthExpanding
PeriodValueYoY Change
2024$96.62M+178.9%
2023$34.65M-8.2%
2022$37.73M-50.4%
2021$76.07M-